HEPATOCELLULAR CANCER
Clinical trials for HEPATOCELLULAR CANCER explained in plain language.
Never miss a new study
Get alerted when new HEPATOCELLULAR CANCER trials appear
Sign up with your email to follow new studies for HEPATOCELLULAR CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail shows promise for tough liver cancers
Disease control OngoingThis study tests whether a combination of three drugs (durvalumab, bevacizumab, tremelimumab) plus a procedure called TACE can help control advanced liver or bile duct cancer. About 27 adults with these cancers will receive the treatment in 21-day cycles. The main goal is to see …
Matched conditions: HEPATOCELLULAR CANCER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 08:28 UTC
-
New combo therapy targets tough cancers
Disease control OngoingThis study tests a new drug called Q702 combined with pembrolizumab (an immunotherapy) in people with advanced esophageal, stomach, liver, or cervical cancer that has worsened after prior treatment. The goal is to see if the combination is safe and shrinks tumors. About 120 parti…
Matched conditions: HEPATOCELLULAR CANCER
Phase: PHASE1, PHASE2 • Sponsor: Qurient Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 08:19 UTC
-
Cancer vaccine trial pulled before it even started
Disease control TerminatedThis study aimed to see if a person's own immune cells, modified in a lab to target specific cancer gene mutations, could prevent gastrointestinal cancers from coming back after standard treatment. It was designed for people with certain gene changes and blood markers suggesting …
Matched conditions: HEPATOCELLULAR CANCER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 06, 2026 16:03 UTC
-
New blood test could spot liver cancer earlier than ultrasound
Diagnosis OngoingThis study is testing a new blood test called Oncoguard™ Liver to see how well it finds liver cancer early in people who are at high risk, such as those with cirrhosis or hepatitis B. About 3,000 adults will take part, and the test's accuracy will be compared to standard ultrasou…
Matched conditions: HEPATOCELLULAR CANCER
Sponsor: Exact Sciences Corporation • Aim: Diagnosis
Last updated May 26, 2026 08:35 UTC
-
Massive liver cancer registry launched to track Real-World treatments and outcomes
Knowledge-focused OngoingThis study follows 10,000 adults with hepatocellular carcinoma (a type of liver cancer) over time to see how the disease naturally progresses and how doctors treat it in routine practice. Researchers will collect information on treatments, side effects, and quality of life. The g…
Matched conditions: HEPATOCELLULAR CANCER
Sponsor: Target PharmaSolutions, Inc. • Aim: Knowledge-focused
Last updated May 22, 2026 13:50 UTC